In contrast to HPGDS, high levels of GSTZ1 predicted higher OS in KIRP, KIRC, and OV patients and higher DFS in KIRC, LGG, and STAD patients (Figure S6A). This evidence concerns the gene GSTZ1 and gastric adenocarcinoma.